QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
QQQ   315.68 (+0.95%)
AAPL   162.36 (+0.99%)
MSFT   284.05 (+1.26%)
META   207.84 (+1.21%)
GOOGL   100.89 (-0.49%)
AMZN   102.00 (+1.75%)
TSLA   195.28 (+0.72%)
NVDA   273.83 (+1.48%)
NIO   10.46 (+6.41%)
BABA   103.38 (+3.46%)
AMD   97.88 (+1.86%)
T   19.08 (+0.42%)
F   12.29 (+1.99%)
MU   63.09 (-0.71%)
CGC   1.76 (-2.76%)
GE   94.05 (-0.01%)
DIS   98.10 (+1.27%)
AMC   4.97 (-0.60%)
PFE   40.38 (+0.32%)
PYPL   74.39 (+0.28%)
NFLX   338.43 (+1.93%)
NYSE:PATH

UiPath - PATH Stock Forecast, Price & News

$16.68
+0.13 (+0.79%)
(As of 03/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$16.55
$17.32
50-Day Range
$13.56
$17.60
52-Week Range
$10.40
$31.88
Volume
5.38 million shs
Average Volume
6.25 million shs
Market Capitalization
$9.22 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.19

UiPath MarketRank™ Forecast

Analyst Rating
Hold
2.47 Rating Score
Upside/​Downside
15.4% Upside
$19.25 Price Target
Short Interest
Bearish
8.32% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.70mentions of UiPath in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$1.55 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.33) to ($0.28) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Business Services Sector

193rd out of 328 stocks

Prepackaged Software Industry

134th out of 213 stocks


PATH stock logo

About UiPath (NYSE:PATH) Stock

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.

Receive PATH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter.

PATH Stock News Headlines

Biden’s Big Lie…
Biden is about to steal the 2024 election... Not through voter suppression, collision with Big Tech, or anything else you might be thinking of. pixel
UiPath Inc. (NYSE:PATH) CAO Sells $204,120.00 in Stock
UiPath Inc. (NYSE:PATH) CFO Ashim Gupta Sells 40,000 Shares
Biden’s Big Lie…
Biden is about to steal the 2024 election... Not through voter suppression, collision with Big Tech, or anything else you might be thinking of. pixel
Why UiPath (PATH) Might be Well Poised for a Surge
UiPath (NYSE:PATH) PT Raised to $17.00 at Barclays
UiPath (NYSE:PATH) Price Target Raised to $20.00
UiPath (NYSE:PATH) PT Raised to $20.00
Company News for Mar 17, 2023
Q4 2022 UiPath Inc Earnings Call
UiPath Named a Leader in RPA by Independent Research Firm
See More Headlines
Receive PATH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter.

PATH Company Calendar

Last Earnings
12/08/2021
Today
3/30/2023
Next Earnings (Estimated)
6/07/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Fax
N/A
Employees
2,863
Year Founded
2005

Price Target and Rating

Average Stock Price Forecast
$19.25
High Stock Price Forecast
$27.50
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
+15.1%
Consensus Rating
Hold
Rating Score (0-4)
2.47
Research Coverage
15 Analysts

Profitability

Net Income
$-328,350,000.00
Pretax Margin
-30.00%

Debt

Sales & Book Value

Annual Sales
$1.06 billion
Book Value
$3.47 per share

Miscellaneous

Free Float
376,591,000
Market Cap
$9.22 billion
Optionable
Not Optionable
Beta
0.60

Social Links


Key Executives

  • Mr. Daniel Solomon Dines (Age 51)
    Co-Founder, Co-CEO & Chairman
    Comp: $669.65k
  • Mr. Ashim  GuptaMr. Ashim Gupta (Age 44)
    Chief Financial Officer
    Comp: $642.52k
  • Mr. Ted  KummertMr. Ted Kummert (Age 60)
    Exec. VP of Products & Engineering
    Comp: $672.56k
  • Mr. Robert Enslin (Age 60)
    Co-Chief Exec. Officer
  • Mr. Marius Tirca
    Co-Founder & CTO
  • Ms. Kelsey Doherty Turcotte
    Sr. VP of Investor Relations
  • Mr. Brad C. BrubakerMr. Brad C. Brubaker (Age 59)
    Gen. Counsel, Chief Legal Officer & Sec.
  • Mr. Robert B. Patrick (Age 51)
    Chief Marketing Officer
  • Mr. Christopher Townsend
    VP of Federal Sales
  • Mr. Vijay Khanna
    Chief Corp. Devel. Officer













PATH Stock - Frequently Asked Questions

Should I buy or sell UiPath stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 8 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PATH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PATH, but not buy additional shares or sell existing shares.
View PATH analyst ratings
or view top-rated stocks.

What is UiPath's stock price forecast for 2023?

15 Wall Street research analysts have issued twelve-month price targets for UiPath's shares. Their PATH share price forecasts range from $14.00 to $27.50. On average, they expect the company's share price to reach $19.25 in the next twelve months. This suggests a possible upside of 14.9% from the stock's current price.
View analysts price targets for PATH
or view top-rated stocks among Wall Street analysts.

How have PATH shares performed in 2023?

UiPath's stock was trading at $12.71 on January 1st, 2023. Since then, PATH shares have increased by 31.8% and is now trading at $16.75.
View the best growth stocks for 2023 here
.

When is UiPath's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 7th 2023.
View our PATH earnings forecast
.

How were UiPath's earnings last quarter?

UiPath Inc. (NYSE:PATH) posted its quarterly earnings results on Wednesday, December, 8th. The healthcare company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.13. The healthcare company had revenue of $220.82 million for the quarter, compared to the consensus estimate of $209.23 million. UiPath had a negative net margin of 31.02% and a negative trailing twelve-month return on equity of 15.38%. UiPath's revenue for the quarter was up 49.9% compared to the same quarter last year.

What guidance has UiPath issued on next quarter's earnings?

UiPath issued an update on its first quarter 2024 earnings guidance on Wednesday, March, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $270.00 million-$272.00 million, compared to the consensus revenue estimate of $269.14 million.

When did UiPath IPO?

(PATH) raised $990 million in an initial public offering (IPO) on Wednesday, April 21st 2021. The company issued 21,300,000 shares at a price of $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities served as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.

What is UiPath's stock symbol?

UiPath trades on the New York Stock Exchange (NYSE) under the ticker symbol "PATH."

Who are UiPath's major shareholders?

UiPath's stock is owned by a number of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (7.97%), Sumitomo Mitsui Trust Holdings Inc. (4.94%), Nikko Asset Management Americas Inc. (4.92%), Alkeon Capital Management LLC (3.20%), Renaissance Technologies LLC (0.96%) and Geode Capital Management LLC (0.92%). Insiders that own company stock include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Hitesh Ramani, Kimberly Hammonds, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert and Thomas Neergaard Hansen.
View institutional ownership trends
.

How do I buy shares of UiPath?

Shares of PATH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UiPath's stock price today?

One share of PATH stock can currently be purchased for approximately $16.75.

How much money does UiPath make?

UiPath (NYSE:PATH) has a market capitalization of $9.26 billion and generates $1.06 billion in revenue each year. The healthcare company earns $-328,350,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.

How many employees does UiPath have?

The company employs 2,863 workers across the globe.

Does UiPath have any subsidiaries?
The following companies are subsidiares of UiPath: Cloud Elements, Cloud Elements Inc., CloudElements Technologies India Private Limited, MagnaView BV, ProcessGold A.G., ProcessGold B.V., ProcessGold International B.V., Re:infer, Shanghai Zhicheng Technology Co. Ltd., StepShot, The Conundrum IP LLC, UiPath AB, UiPath Australia Pty Ltd, UiPath Austria GmbH, UiPath Belgium BVBA, UiPath Brasil Consultoria Limitada, UiPath Business Solutions India Private Limited, UiPath Canada Operations Ltd., UiPath Denmark ApS, UiPath Finland Oy, UiPath France SAS, UiPath GMBH, UiPath Inc., UiPath Israel LTD, UiPath Italy SRL, UiPath Kabushiki Kaisha, UiPath Korea Ltd., UiPath Limited (Hong Kong), UiPath Ltd. (UK), UiPath Mexico S. DE R.L. DE C.V., UiPath Netherlands B.V., UiPath Netherlands Holding B.V., UiPath Norway AS, UiPath OOO, UiPath PTE LTD, UiPath Process Mining, UiPath Robotic Process Automation India Private Limited, UiPath SRL, UiPath South Africa (Pty) LTD, UiPath Switzerland GmbH, UiPath Ukraine LLC, and UiPath Ventures LLC.
Read More
How can I contact UiPath?

UiPath's mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The official website for the company is www.uipath.com. The healthcare company can be reached via phone at 844-432-0455 or via email at investor.relations@uipath.com.

This page (NYSE:PATH) was last updated on 3/30/2023 by MarketBeat.com Staff